发明名称 LUNG CANCER MARKER AND USE THEREOF
摘要 <p>PROBLEM TO BE SOLVED: To provide a lung cancer marker and a use thereof.SOLUTION: Methods and compositions are provided for assessing (e.g., diagnosing), treating, and preventing diseases, especially cancer, and particular lung cancer, using lung cancer markers (LCM). Individual LCM and panels comprising multiple LCM are provided for these and other uses. Methods and compositions are also provided for determining or predicting the effectiveness of a treatment or for selecting a treatment using LCM. Methods and compositions are further provided for modulating cell function using LCM. Also provided are compositions that modulate LCM (e.g., antagonists or agonists), such as antibodies, proteins, small molecule compounds, and nucleic acid agents (e.g., RNAi and antisense agents), as well as pharmaceutical compositions thereof. Further provided are methods of screening for agents that modulate LCM, and agents identified by these screening methods.</p>
申请公布号 JP2015143716(A) 申请公布日期 2015.08.06
申请号 JP20150096386 申请日期 2015.05.11
申请人 CELERA CORP 发明人 CHARLES BIRSE;STEVE RUBEN;MARCIA LEWIS;MEHDI MESRI
分类号 G01N33/574;C12Q1/68;G01N33/543;G01N33/577 主分类号 G01N33/574
代理机构 代理人
主权项
地址